azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['azacitidine,(-oral azaci),(-azacitidine oral)', 'venetoclax', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'leukemia', 'immunogen ', 'imab ', '$imgn']
$imgn key findings from the phase 1b/2 study of #pivekimab sunirine in combination with #azacitidine and #venetoclax in patients with #cd123-positive #aml presented in an oral presentation today at #ash22. read the full release here: 
We exist to interrupt the progress of cancer so cancer can't interrupt the lives of our patients. #TargetABetterNow

Policy: https://t.co/MLtPQiuFPo